Synthetic biology company launches JV to commercialize gas-to-liquids bioconversion; isobutanol first target
Green Car Congress
MARCH 28, 2014
Intrexon says that its biocatalyst approach to GTL bioconversion reduces energy use, production costs, and waste while producing a single high value product. Intrexon says it has already achieved initial proof of concept with an engineered microbial host converting methane into isobutanol in a laboratory-scale bioreactor.
244 
Let's personalize your content